leisure time -WSS

leisure time

author：focus 2025-09-03 18:45:16 - browse：6

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

WSS

Illinois to ban advertising for guns allegedly marketed to kids and militants

How Vertex's cystic fibrosis drug is changing patients' lives

Senators: Long

Biotech lab space demand falls sharply

Hearing on Medicare drug price negotiation gets unusually heated

Democratic lawmaker calls for 'well

focus

leisure time

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Medicare details structure of new drug price negotiation program

It's been 20 years since Dolly the sheep. Where's my clone?

Alkermes shareholders re

Mississippi candidates for statewide offices square off in party primaries

Jerome Adams on the need for new antivirals for Covid

Moderna hits safety problems in bold bid to reinvent medicine

focus

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Ukraine and a new approach to mental health in war

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

NYC plans to house migrants on an island in the East River

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

focus

leisure time

focus

leisure time